Skip to content

Biomarkers and Mild Behavioural Impairment (BAMBI)

Cognition | Memory Disorders

This study enrolls community dwelling adults over the age of 40 for assessments of cognition, behaviour, function, quality of life, and caregiver stress, in association with biomarkers, at 18 month intervals. Participants attend with a study partner, and at each visit are given a series of questionnaires and tests. The overall visit is ~2.5 hours in duration. Biomarkers of inflammation and neurodegeneration are obtained via a participant blood draw and urine collection at each visit. Additionally, participants will be given a stool collection kit to take home which will be returned to the lab for gut microbiome analysis.

null

Conditions de participation

  • Sexe:

    Male, Female, Intersex

  • Âges admissibles:

    40 and up

Critères de participation

Inclusion Criteria:
1. Age 40 or older with normal cognition, subjective cognitive decline, mild cognitive impairment, mild AD dementia, or moderate AD dementia.
2. Study partner available who has known the participant for ≥5 years

Exclusion Criteria:
1. Developmental disorders and neuropsychiatric conditions that would affect testing (e.g., autism, Huntington’s disease, schizophrenia, bipolar disorder)
2. Unable to provide informed consent
3. No study partner
4. Not fluent in English

Lieu de l'étude

University of Calgary
University of Calgary
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Étude parrainée par
University of Calgary
Participants recherchés
Plus d'informations
ID de l'étude: REB21-1463